A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and Wegovy. Researchers believe nearly 25,000 hospital visits occurred ...

You may have heard about Ozempic, a medicine for type 2 diabetes approved by the FDA in 2017. This medicine is for use with diet and exercise to improve control of blood glucose levels in people ...

Forget Ozempic face – should we be worried about Ozempic teeth? - LET’S UNPACK THAT: With more and more people signing up for weight loss drugs, the potential side effects are starting to ...

Find patient medical information for Ozempic (semaglutide) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

Drugs like Ozempic have ushered in a new era for weight loss, promising an unprecedented fast-track to shedding pounds. But it’s not just fat that gets shed. Research shows those who take these ...

Ozempic is a brand-name drug used to treat type 2 diabetes. Learn about the common, mild, and serious side effects it can cause and how to manage them.

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications. For those preferring a ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show the medications for Type 2 diabetes and weight loss can decrease the ...

As weight-loss injectables like Ozempic skyrocket in popularity, a new offshoot trend is starting to take hold: microdosing.. Instead of following the standard dosing guidelines, some people are ...

Ozempic is a prescription drug approved to treat type 2 diabetes and used off-label for weight loss. Learn about foods you may want to avoid during treatment.

A new study adds to mounting evidence showing that drugs like Ozempic don’t just treat diabetes — they can also prevent it. The new paper, published Wednesday in The New England Journal of ...